GSA Capital Partners’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-9,243
| Closed | -$374K | – | 1976 |
|
|
2025
Q3 | $374K | Sell |
9,243
-33,423
| -78% | -$1.1M | 0.03% | 1060 |
|
|
2025
Q2 | $1.09M | Buy |
42,666
+33,117
| +347% | +$722K | 0.08% | 405 |
|
|
2025
Q1 | $204K | Sell |
9,549
-6,915
| -42% | -$155K | 0.02% | 1389 |
|
|
2024
Q4 | $346K | Buy |
+16,464
| New | +$381K | 0.03% | 1130 |
|
|
2024
Q1 | – | Sell |
-81,562
| Closed | -$944K | – | 1879 |
|
|
2023
Q4 | $944K | Sell |
81,562
-85
| -0.1% | -$959 | 0.08% | 426 |
|
|
2023
Q3 | $1.04M | Buy |
81,647
+56,676
| +227% | +$804K | 0.09% | 372 |
|
|
2023
Q2 | $342K | Buy |
+24,971
| New | +$358K | 0.03% | 970 |
|
|
2022
Q4 | – | Sell |
-22,763
| Closed | -$303K | – | 1775 |
|
|
2022
Q3 | $303K | Sell |
22,763
-8,620
| -27% | -$149K | 0.04% | 923 |
|
|
2022
Q2 | $600K | Sell |
31,383
-7,978
| -20% | -$151K | 0.09% | 383 |
|
|
2022
Q1 | $785K | Buy |
39,361
+4,506
| +13% | +$91K | 0.11% | 279 |
|
|
2021
Q4 | $712K | Sell |
34,855
-5,395
| -13% | -$115K | 0.09% | 376 |
|
|
2021
Q3 | $867K | Buy |
40,250
+20,454
| +103% | +$492K | 0.09% | 375 |
|
|
2021
Q2 | $572K | Sell |
19,796
-2,345
| -11% | -$63.4K | 0.06% | 544 |
|
|
2021
Q1 | $540K | Buy |
22,141
+1,180
| +6% | +$26.7K | 0.09% | 312 |
|
|
2020
Q4 | $407K | Buy |
20,961
+5,309
| +34% | +$97.7K | 0.07% | 556 |
|
|
2020
Q3 | $272K | Buy |
+15,652
| New | +$334K | 0.05% | 816 |
|
|
2020
Q2 | – | Sell |
-8,456
| Closed | -$204K | – | 978 |
|
|
2020
Q1 | $204K | Sell |
8,456
-7,393
| -47% | -$181K | 0.05% | 750 |
|
|
2019
Q4 | $394K | Buy |
+15,849
| New | +$368K | 0.05% | 828 |
|
|
2019
Q2 | – | Sell |
-21,177
| Closed | -$699K | – | 1664 |
|
|
2019
Q1 | $699K | Buy |
21,177
+3,010
| +17% | +$93.7K | 0.07% | 494 |
|
|
2018
Q4 | $584K | Sell |
18,167
-9,848
| -35% | -$372K | 0.07% | 477 |
|
|
2018
Q3 | $1.2M | Buy |
28,015
+3,067
| +12% | +$145K | 0.07% | 554 |
|
|
2018
Q2 | $1.15M | Buy |
+24,948
| New | +$1.1M | 0.06% | 658 |
|
|
2017
Q2 | – | Sell |
-33,647
| Closed | -$945K | – | 1879 |
|
|
2017
Q1 | $945K | Buy |
33,647
+17,453
| +108% | +$492K | 0.05% | 673 |
|
|
2016
Q4 | $474K | Sell |
16,194
-17,206
| -52% | -$470K | 0.03% | 1029 |
|
|
2016
Q3 | $908K | Sell |
33,400
-4,686
| -12% | -$106K | 0.05% | 667 |
|
|
2016
Q2 | $711K | Buy |
+38,086
| New | +$794K | 0.04% | 857 |
|
|
2015
Q3 | – | Sell |
-16,500
| Closed | -$643K | – | 1960 |
|
|
2015
Q2 | $643K | Buy |
+16,500
| New | +$569K | 0.02% | 1193 |
|
Other funds holding PAHC
GSA Capital Partners's PAHC Position: Q4 2025 in Review
GSA Capital Partners sold out of Phibro Animal Health (PAHC) in Q4 2025, closing a stake of 9,243 shares — an estimated $374K sold.
GSA Capital Partners first reported a position in PAHC in Q2 2015 and held it in 27 quarters. The position peaked at $1.2M in Q3 2018. 227 funds tracked by Wall St. Rank hold PAHC as of Q4 2025.
- GSA Capital Partners reported no remaining Phibro Animal Health position as of Q4 2025 after selling out during the quarter.
- GSA Capital Partners sold 9,243 Phibro Animal Health shares in Q4 2025, an estimated $374K.
- GSA Capital Partners first reported a position in Phibro Animal Health in Q2 2015 and held it in 27 quarters.
- GSA Capital Partners's Phibro Animal Health position peaked at $1.2M in Q3 2018.
- 227 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2025.
Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.